Trending Now
Business
‘Shock Exchange’ Predicted General Electric’s Demise, But No One Listened
General Electric nearly collapsed in 2009 after the commercial paper market cratered. GE had to beg President Obama for a taxpayer bailout to protect...
Trump Threatens To Sue Opioid Drug Makers
President Donald Trump stepped up criticism of opioid drug manufacturers. He recently intimated he was considering suing drugmakers for their role in fueling the...
Lifestyle today
Entertainment
In Praising Trump, Mark Cuban Hates On Shock Exchange
The coronavirus and low oil prices have presented a dilemma Fed Chairman Jerome Powell cannot fix by simply printing money. You cannot current the...
Will Black Ryan Fitzpatrick Show Up Against The Steelers?
It is only three weeks into the NFL season an the narratives are starting to build. The Kansas City Chiefs look like a locomotive...
Trump and the GE Endorses Maria Chappelle-Nadal For Congress
Trump and the Global Economy (“Trump and the GE”) explains the economy and key drivers of the economy in layman’s terms. We...
Experts Predict The Company Most-Likely To Approach Endo
On February 11th women discussed the commercial appeal of Endo's Xiaflex to treat cellulite. Xiaflex could become the first non-surgical treatment for cellulite, which...
Governor Bartell: ‘How Come We Aren’t Marching In The Street About Black-On-Black Crime?’
Future Georgia Governor Al Bartell graced Trump And The GE earlier this week to discuss his background, the political climate in Georgia...
Draymond Green, Warriors Skip White House Visit
The Golden State Warriors have dominated the NBA over the past few years, winning three of the previous four NBA titles. They went 73-9...
Endo: Takeda Deal For Generic Colcrys Is Bullish For 2 Reasons
Things are starting to look up for Endo International (ENDP). Last month Citigroup (C) upgraded the company to "buy" and highlighted Endo's "next big...
Mallinckrodt: Has Insys Discovered The Acthar Killer?
Mallinckrodty delivered a Q4 revenue and earnings beat, which caused the stock to spike 15%:
Mallinckrodt's Q4 revenue fell 5% Y/Y. I was expecting another...






















































































































